Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

FDA Warns Doctors: Suddenly Stopping Opioid Painkillers Is Harmful

Friday 3 May 2019


From ProHealth:



FDA Warns Doctors: Suddenly Stopping Opioid Painkillers Is Harmful

By Karen Lee Richards
April 25, 2019
Copyright © 2019 ProHealth, Inc. All rights reserved.

Something chronic pain patients have long known––that suddenly discontinuing opioid medication can be harmful and even dangerous––has finally been confirmed by the FDA.

On April 9, 2019, the U.S. Food and Drug Administration (FDA) announced that it had “received reports of serious harm in patients who are physically dependent on opioid pain medicines suddenly having these medicines discontinued or the dose rapidly decreased.” They noted that the harm included serious opioid withdrawal symptoms, uncontrolled pain, psychological distress, and suicide.

Acting on this information, the FDA is now going to require changes to prescribing information for opioid medications that are intended for use in the outpatient setting. The changes will include expanded guidance for prescribers on how to safely taper patients off of opioids, decreasing the dose gradually and individualizing the plan for each patient.


Full article…



blog comments powered by Disqus
Previous Previous Page